AIRS — AirSculpt Technologies, Inc. stock price, charts and financials
QT35AirSculpt Technologies, Inc.AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -0.18 | Insider Own | - | Shs Outstand | 70.55M | Perf Week | -4.55% |
| Market Cap | 162.96M | Forward P/E | - | EPS next Y | -0.04 | Insider Trans | 0.64% | Shs Float | 14.96M | Perf Month | -17.79% |
| Enterprise Value | 206.96M | PEG | - | EPS next Q | -0.03 | Inst Own | - | Short Float | 4.26% | Perf Quarter | -53.24% |
| Income | -12.00M | P/S | 1.09 | EPS this Y | 55.56% | Inst Trans | - | Short Ratio | 4.29 | Perf Half Y | -15.07% |
| Sales | 150.00M | P/B | 1.55 | EPS next Y | 43.75% | ROA | -6.07% | Short Interest | 3.00M | Perf YTD | 16.67% |
| Book/sh | 1.49 | P/C | 8.58 | EPS next 5Y | - | ROE | -12.52% | 52W High | 12.00 -80.75% | Perf Year | -62.68% |
| Cash/sh | 0.27 | P/FCF | - | EPS past 3/5Y | - | ROIC | -5.46% | 52W Low | 1.51 52.98% | Perf 3Y | -69.57% |
| Dividend Est. | - | EV/EBITDA | 68.99 | Sales past 3/5Y | -3.47% 19.26% | Gross Margin | 57.63% | Volatility | 6.90% 7.06% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.38 | EPS Y/Y TTM | -28.57% | Oper. Margin | -7.85% | ATR (14) | 0.23 | Perf 10Y | - |
| Dividend Ex-Date | Aug 25, 2022 | Quick Ratio | 0.79 | Sales Y/Y TTM | -16.67% | Profit Margin | -7.79% | RSI (14) | 36.75 | Recom | 2.60 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.79 | EPS Q/Q | - | SMA20 | -7.77% | Beta | 2.90 | Target Price | 4.50 |
| Payout | 0.00% | Debt/Eq | 0.86 | Sales Q/Q | -2.27% | SMA50 | -33.83% | Rel Volume | 1.43 | Prev Close | 2.30 |
| Employees | 347 | LT Debt/Eq | 0.81 | Earnings | Nov 09 | SMA200 | -28.69% | Avg Volume | 741.79K | Price | 2.31 |
| IPO Date | Oct 29, 2021 | Option/Short | No / Yes | EPS/Sales Surpr. | -33.33% -2.80% | Net Debt/EBITDA | 15.11 | Volume | 1,059,094 | Change | 0.43% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-14-26 | Reiterated | Leerink Partners | Market Perform | $3.00 → $4.50 |
| Nov-11-25 | Reiterated | Leerink Partners | Market Perform | $5.00 → $6.00 |
| May-14-24 | Downgrade | Leerink Partners | Outperform → Market Perform | $5.00 |
| Nov-11-22 | Reiterated | Piper Sandler | $4.00 | |
| Aug-24-22 | Reiterated | Morgan Stanley | Equal Weight | |
| Jun-16-22 | Downgrade | Morgan Stanley | Overweight → Equal Weight |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 150 | 152 | 180 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 65 | 62 | 71 | — | — | — | — | — | |
| Gross Profit | 87 | 90 | 109 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 86 | 82 | 106 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 13 | 13 | 5 | — | — | — | — | — | |
| Operating Income | -13 | -5 | -2 | — | — | — | — | — | |
| Interest Expense | 4 | 6 | 6 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 3 | -7 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | -14 | -18 | -8 | — | — | — | — | — | |
| Income Taxes | -2 | -6 | 0 | — | — | — | — | — | |
| Consolidated Net Income | -12 | -12 | -8 | — | — | — | — | — | |
| Net Income From Continuing Operations | -12 | -12 | -8 | — | — | — | — | — | |
| Net Income | -12 | -12 | -8 | — | — | — | — | — | |
| EPS (Recurring) | -0.18 | -0.19 | -0.14 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.18 | -0.19 | -0.14 | — | — | — | — | — | |
| EPS (Diluted) | -0.18 | -0.19 | -0.14 | — | — | — | — | — | |
| EBITDA | 3 | 1 | 10 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.09 | 0.78 | 1.67 | — | — | — | — | — | |
| Gross Margin | 58.00 | 59.21 | 60.56 | — | — | — | — | — | |
| Operating Margin | -8.67 | -3.29 | -1.11 | — | — | — | — | — | |
| Net Margin | -8.00 | -7.89 | -4.44 | — | — | — | — | — | |
| Shares Outstanding | 71 | 60 | 58 | — | — | — | — | — | |
| Market Capitalization | 164 | 119 | 301 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Chernett Jorey | 10% Owner | Apr 17 '26 | Buy | 2.54 | 40,000 | 101,600 | 7,053,761 | Apr 20 |
| Chernett Jorey | 10% Owner | Apr 14 '26 | Buy | 2.60 | 20,000 | 52,000 | 7,013,761 | Apr 15 |
| Chernett Jorey | 10% Owner | Apr 07 '26 | Buy | 2.93 | 60,000 | 175,800 | 6,993,761 | Apr 08 |
| Chernett Jorey | 10% Owner | Apr 03 '26 | Buy | 2.82 | 90,000 | 253,800 | 6,933,761 | Apr 06 |
| Chernett Jorey | 10% Owner | Mar 23 '26 | Buy | 2.99 | 56,259 | 168,026 | 6,843,761 | Mar 25 |
| Chernett Jorey | 10% Owner | Mar 23 '26 | Sale | 2.00 | 6,547 | 13,094 | 0 | Mar 25 |
| Chernett Jorey | 10% Owner | Mar 20 '26 | Buy | 2.77 | 40,000 | 110,800 | 6,793,761 | Mar 23 |
| Chernett Jorey | 10% Owner | Mar 19 '26 | Buy | 2.64 | 77,702 | 205,133 | 6,753,761 | Mar 20 |
| Chernett Jorey | 10% Owner | Mar 17 '26 | Buy | 2.56 | 83,000 | 212,480 | 6,676,059 | Mar 18 |
| Chernett Jorey | 10% Owner | Mar 16 '26 | Buy | 2.43 | 105,848 | 257,211 | 6,592,059 | Mar 16 |
| Chernett Jorey | 10% Owner | Mar 11 '26 | Buy | 2.15 | 88,000 | 189,200 | 6,486,211 | Mar 11 |
| Chernett Jorey | 10% Owner | Mar 06 '26 | Buy | 2.00 | 45,600 | 91,200 | 6,398,211 | Mar 09 |
| Chernett Jorey | 10% Owner | Mar 04 '26 | Buy | 1.87 | 30,000 | 56,100 | 6,352,611 | Mar 04 |
| Chernett Jorey | 10% Owner | Mar 03 '26 | Buy | 1.71 | 80,000 | 136,800 | 6,322,611 | Mar 04 |
| Jashnani Yogesh | Chief Executive Officer | Oct 27 '25 | Option Exercise | 0.00 | 112,194 | 56 | 520,976 | Oct 29 |